An epidemiological study on the factors including genetic polymorphism influencing ALT >30 U/L and liver fibrosis progression in metabolic dysfunction‐associated steatotic liver disease among the general population

An epidemiological study on the factors including genetic polymorphism influencing ALT >30 U/L and liver fibrosis progression in metabolic dysfunction‐associated steatotic liver disease among the general population

Abstract Background and Aim Identifying the factors contributing to the progression of metabolic dysfunction‐associated steatotic liver disease (MASLD), a lifestyle‐related disease, is crucial for preventing future liver‐related deaths. This study aimed to epidemiologically investigate factors, incl...

Full description

Saved in:
Bibliographic Details
Main Authors: Satoshi Sato, Chikara Iino, Takafumi Sasada, Go Soma, Keisuke Furusawa, Kenta Yoshida, Kaori Sawada, Tatsuya Mikami, Shinsaku Fukuda, Shigeyuki Nakaji, Hirotake Sakuraba
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:JGH Open
Subjects:
cardiovascular metabolic risk factors
lifestyle
liver fibrosis
metabolic dysfunction‐associated steatotic liver disease
single‐nucleotide polymorphisms
Online Access:https://doi.org/10.1002/jgh3.70043
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jgh3.70043

Similar Items